For cancer patients, e-cigarettes not helpful for smoking cessation
the ONA take:
According to a new study published in the journal Cancer, patients with cancer who use e-cigarettes as a form of smoking cessation are equally or less likely to quit smoking compared with those who do not use e-cigarettes. Researchers from Memorial Sloan-Kettering Cancer Center in New York City, New York, sought to examine whether cancer patients using e-cigarettes affect smoking cessation due to the increased use of the device.
In the study, researchers followed 1,074 patients with cancer that smoke who were receiving care at a comprehensive cancer center and also part of a tobacco treatment program between 2012 and 2013. During that time, e-cigarette use rose from 10.6% to 38.5% of patients.
At follow-up, researchers found that the patients using e-cigarettes were equally as likely as non-users to still be smoking cigarettes. Furthermore, patients using e-cigarettes were found to be twice as likely to be regular smokers of cigarettes compared with non-users.
The American Cancer Society does not recommend for or against the the use of e-cigarettes for smoking cessation due to the lack of known and benefits and potential risks associated with long-term use.
Patients with cancer who use e-cigarettes are equally or less likely to quit smoking.
Despite the well-documented risks to health that are posed by smoking, previous research has shown that smoking habits can continue long after a cancer diagnosis has been made. The authors of the new study state that approximately two thirds of smokers diagnosed with cancer continue to do so after diagnosis.
This continuation is problematic, as smoking can cause new mutations among cancer survivors, resulting in secondary or further forms of primary cancer. Smoking can also reduce how effective cancer treatments are.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|